L3Harris's VAMPIRE rockets were already popular. And now they've got AI.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

Rocket Lab (RKLB) stock has traded between $39.48 and $150.23 over the past 52 weeks. It now sits about 58% below its 52-week high, and anyone who bought twelve months ago is still up about 19%. None of that tells you what you would be buying today. Rocket Lab sells two quite different things, and the one its name points at is the smaller of them.
Guggenheim says operating margins run materially above peers

Palantir Technologies (NASDAQ:PLTR) used its AIPCon event to highlight customer deployments of its Foundry, Ontology and Artificial Intelligence Platform products across supply chains, aviation safety, defense manufacturing, insurance, media, pharmaceuticals and industrial operations. Speakers repea

FEATURE Defense stocks have been surprisingly lousy lately. That could change as the midterm elections approach. Wall Street has some new ideas for investors to consider. Coming into Tuesday trading, the exchange-traded fund was down 7% since the start of the Iran war in late February, underperforming the by almost 20 percentage points.

Lockheed Martin (LMT) has spent the past three years handing its owners a slightly bigger slice of the company each year, and the arithmetic worked. Earnings per share grew faster than net income. The stock now sits well below its 52-week high, which makes the question worth asking again: is that quiet compounding still running at the speed the record suggests.

Intuitive Machines' surging revenues and record backlog strengthen its growth case, but rich valuation, cash use and execution risks keep the investment setup balanced.

A veteran investor openly admits he wants SpaceX shares but refuses to touch them, and his reasoning points to a risk most retail investors are completely overlooking before the stock even opens for trading.
LHX tops Q2 earnings and revenue estimates, delivers growth across all segments and raises its 2026 outlook.
Boeing (BA) delivered earnings and revenue surprises of -123.53% and +2.11%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Here are four defense stocks that are expected to post an earnings beat this reporting cycle.
GE surges over the past year, but rich valuation, higher costs and debt may give new investors reason to wait for a better entry.
L3Harris (LHX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
L3Harris Technologies, Inc. (NYSE:LHX) is one of the Best Space Technology Stocks to Buy Now. Recently, on July 1, L3Harris Technologies, Inc. (NYSE:LHX) announced receiving an FAA contract to upgrade and operate the nation’s aircraft tracking network through 2045. Management noted that under this contract, the company will modernize more than 700 ground stations. These […]
Is LHX a good stock to buy? We came across a bullish thesis on L3Harris Technologies, Inc. on r/investing_discussion by Variant_Invest. In this article, we will summarize the bulls’ thesis on LHX. L3Harris Technologies, Inc.’s share was trading at $308.17 as of June 9th. LHX’s trailing and forward P/E were 33.46 and 27.17 respectively according to Yahoo […]
L3Harris Technologies, Inc. (NYSE:LHX) is included among the 10 Best Stocks to Buy Now for a $1 Million Portfolio. On May 4, Bernstein analyst Douglas Harned lowered the firm’s price recommendation on L3Harris Technologies, Inc. (NYSE:LHX) to $405 from $435. It reiterated an Outperform rating on the shares. The firm pointed to the company’s first-quarter […]
LHX tops first-quarter estimates as revenues rise across all segments on new program ramp-up and higher international volume, and lifts its 2026 EPS outlook.
L3Harris Technologies (NYSE:LHX) reported first-quarter results on Thursday that exceeded analyst expectations, though shares edged lower in premarket trading as investors weighed the company’s updated outlook. The stock dipped 0.

